NLH — Nova Leap Health Income Statement
0.000.00%
Last trade - 00:00
- CA$18.97m
- CA$19.65m
- $26.18m
- 89
- 89
- 75
- 97
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17.4 | 17.3 | 21.3 | 28.2 | 26.2 |
Cost of Revenue | |||||
Gross Profit | 5.84 | 5.87 | 7.21 | 9.98 | 9.77 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 17.6 | 18.7 | 18.3 | 30 | 27 |
Operating Profit | -0.231 | -1.4 | 2.97 | -1.83 | -0.795 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.951 | 0.126 | 2.47 | -1.21 | -1.37 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.06 | 1.26 | 1.76 | -0.836 | -1.05 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.06 | 1.26 | 1.76 | -0.836 | -1.05 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.06 | 1.26 | 1.76 | -0.836 | -1.05 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.016 | 0.029 | -0.012 | -0.004 | -0.003 |